CL2015003507A1 - Beta-caseína a2 y prevención de inflamación del intestino - Google Patents

Beta-caseína a2 y prevención de inflamación del intestino

Info

Publication number
CL2015003507A1
CL2015003507A1 CL2015003507A CL2015003507A CL2015003507A1 CL 2015003507 A1 CL2015003507 A1 CL 2015003507A1 CL 2015003507 A CL2015003507 A CL 2015003507A CL 2015003507 A CL2015003507 A CL 2015003507A CL 2015003507 A1 CL2015003507 A1 CL 2015003507A1
Authority
CL
Chile
Prior art keywords
beta
casein
bowel inflammation
inflammation prevention
prevention
Prior art date
Application number
CL2015003507A
Other languages
English (en)
Inventor
Andrew John Clarke
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015003507(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of CL2015003507A1 publication Critical patent/CL2015003507A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UNA COMPOSICIÓN QUE COMPRENDE BETA-CASEÍNA A2 PARA LA PREVENCIÓN DE INFLAMACIÓN DEL INTESTINO EN UNA ANIMAL
CL2015003507A 2013-05-31 2015-11-30 Beta-caseína a2 y prevención de inflamación del intestino CL2015003507A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31

Publications (1)

Publication Number Publication Date
CL2015003507A1 true CL2015003507A1 (es) 2016-12-16

Family

ID=51989162

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015003507A CL2015003507A1 (es) 2013-05-31 2015-11-30 Beta-caseína a2 y prevención de inflamación del intestino

Country Status (20)

Country Link
US (2) US20160113997A1 (es)
EP (2) EP3003485B1 (es)
JP (2) JP6867158B2 (es)
KR (2) KR102402455B1 (es)
CN (2) CN105407971B (es)
AU (2) AU2014271423B2 (es)
BR (1) BR112015029987A8 (es)
CA (1) CA2913890A1 (es)
CL (1) CL2015003507A1 (es)
DK (1) DK3003485T3 (es)
ES (1) ES2742306T3 (es)
HK (1) HK1222362A1 (es)
IL (2) IL242833B (es)
MX (2) MX367794B (es)
MY (1) MY179497A (es)
PH (2) PH12015502674B1 (es)
RU (1) RU2669553C2 (es)
SG (2) SG10201709509RA (es)
WO (1) WO2014193248A1 (es)
ZA (1) ZA201508983B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201709509RA (en) * 2013-05-31 2017-12-28 A2 Milk Co Ltd Beta-Casein A2 And Prevention Of Inflammation Of The Bowel
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
CN106455662A (zh) * 2014-06-03 2017-02-22 雅培制药有限公司 包含亲脂性活性成分的营养组合物
CA2986889C (en) * 2015-05-22 2023-08-29 The A2 Milk Company Limited Beta-casein a2 and antioxidant capacity
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
NZ746167A (en) 2016-03-30 2023-04-28 A2 Milk Co Ltd Beta-caseins and cognitive function
JP6873234B2 (ja) * 2016-09-30 2021-05-19 ズィ・エイツー・ミルク・カンパニー・リミテッド ベータカゼイン類および腸微生物叢
WO2018069362A1 (en) * 2016-10-14 2018-04-19 F. Hoffmann-La Roche Ag Imidazole compounds as eaat3 inhibitors
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530A (zh) * 2022-11-15 2023-02-24 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691362B2 (en) 1994-11-04 1998-05-14 New Zealand Dairy Board Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
DK0871366T3 (da) 1995-05-16 2005-10-10 A2 Corp Ltd Födevareprodukt og fremgangsmåde til fremstilling heraf
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
EP1196047A4 (en) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
WO2002083164A2 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
EP2068908B1 (en) * 2006-10-06 2014-07-16 Kerry Group Services International Limited A milk protein composition and use thereof
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
SG10201709509RA (en) * 2013-05-31 2017-12-28 A2 Milk Co Ltd Beta-Casein A2 And Prevention Of Inflammation Of The Bowel

Also Published As

Publication number Publication date
JP7224242B2 (ja) 2023-02-17
SG10201709509RA (en) 2017-12-28
IL262302B (en) 2021-02-28
MX2019010594A (es) 2019-10-15
CN112316116A (zh) 2021-02-05
NZ714912A (en) 2021-06-25
BR112015029987A8 (pt) 2021-12-07
PH12015502674A1 (en) 2016-03-07
ZA201508983B (en) 2017-11-29
RU2015153113A (ru) 2017-07-05
US11911439B2 (en) 2024-02-27
BR112015029987A2 (pt) 2017-07-25
JP2016520611A (ja) 2016-07-14
AU2018274937A1 (en) 2019-01-03
DK3003485T3 (da) 2019-08-19
PH12015502674B1 (en) 2016-03-07
PH12019550096A1 (en) 2020-02-10
US20200179485A1 (en) 2020-06-11
KR20160024884A (ko) 2016-03-07
MX367794B (es) 2019-09-06
AU2014271423A1 (en) 2015-12-24
RU2669553C2 (ru) 2018-10-12
WO2014193248A1 (en) 2014-12-04
US20160113997A1 (en) 2016-04-28
EP3003485A1 (en) 2016-04-13
HK1222362A1 (zh) 2017-06-30
KR102282972B1 (ko) 2021-07-28
AU2014271423B2 (en) 2018-12-20
EP3003485B1 (en) 2019-05-15
CN105407971A (zh) 2016-03-16
CA2913890A1 (en) 2014-12-04
CN105407971B (zh) 2020-11-17
RU2018131733A3 (es) 2021-10-29
JP6867158B2 (ja) 2021-04-28
RU2018131733A (ru) 2018-11-08
EP3003485A4 (en) 2016-11-30
EP3542813A1 (en) 2019-09-25
KR102402455B1 (ko) 2022-05-25
AU2018274937B2 (en) 2020-10-29
MY179497A (en) 2020-11-09
JP2019165746A (ja) 2019-10-03
IL242833B (en) 2019-07-31
ES2742306T3 (es) 2020-02-13
SG11201509769QA (en) 2015-12-30
IL262302A (en) 2018-11-29
KR20210094674A (ko) 2021-07-29
MX2015016493A (es) 2016-08-18

Similar Documents

Publication Publication Date Title
CL2015003507A1 (es) Beta-caseína a2 y prevención de inflamación del intestino
FR21C1059I2 (fr) Compositions pharmaceutiques
IL258081B (en) Benzimidazole history and their use
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
IL246221A0 (en) Endazoles and their uses
CL2015003704A1 (es) Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer
BR112017012804A2 (pt) composições para higiene bucal e métodos de uso.
CL2013003577A1 (es) Uso de una composicion farmaceutica que comprende panobinostat y ruxolitinib en la prevencion y/o tratamiento de neoplasias mieloproliferativas.
KR102068915B9 (ko) 조직 인자 경로 억제제 항체 및 그의 용도
DK2996465T3 (da) Fiskeopdrætsanlæg og anvendelse deraf
CL2015002180A1 (es) Terapia de combinación para el tratamiento de neumonía nosocomial
PL3064491T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio
PL2910131T3 (pl) Kompozycja przeciwdziałająca zmęczeniu i jej zastosowanie
BR112019006844A2 (pt) prevenção de alergia
BR112017010700A2 (pt) combinação de ibudilaste e riluzol e métodos de uso da mesma
CL2015001446A1 (es) Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido.
BR112016004943A2 (pt) aparelho médico e uso
IL261645A (en) History of dioxo-hexahydroisoindolyl and their use as cyclophilin inhibitors
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
CL2015002389A1 (es) Composiciones herbicidas que contienen isoxabena y flufenaceto.
BR112016026470A2 (pt) Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
PT2944309T (pt) Utilização de palmitoiletanolamida em combinação com opióides
BR112015020849A2 (pt) ésteres de testosterona de cadeia longa lipobalanceados para entrega oral